• By Sarah Campian, MS, CGC
  • Posted October 21, 2025

The Gene Scene: MSH2

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified


  • By Kimia Sanati, MS, CGC
  • Posted October 14, 2025

The Gene Scene: CDKN2A

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications.* These genes are included because they’re linked to serious but preventable or manageable conditions when identified…


  • By Candela Delucchi
  • Posted August 26, 2025

Making Waves: Honoring a Mother’s Final Wish Through Creative Care

Meet Arravinth (Avi) Anantharajah, MS, LCGC, a genetic counselor with the Cancer Risk Evaluation Program at the University of Pennsylvania’s Basser Center for BRCA. In our Making Waves series, we’ve spotlighted the inspiring work of healthcare providers across our industry. Learn the remarkable story of one family’s determination to complete…


  • By Bradley Power, MS, CGC
  • Posted August 5, 2025

The Gene Scene: TGFBR1

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified


  • By Carrie Horton, MS, CGC
  • Posted May 30, 2024

Research Recap: Determining Gene-Disease Validity in POT1 Tumor Predisposition

Germline variants in POT1 have been implicated in predisposition to melanoma, sarcoma and glioma. However, these tumor associations have been derived from very small studies, or those with cohorts highly ascertained for specific cancers. In our recent study in Genetics and Medicine regarding POT1 tumor predisposition syndrome, Ambry set out to…


  • By Meagan Farmer
  • Posted May 22, 2024

The Power of Progress: Philip's NF1 Clinical Trial Experience

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You…


  • By Meagan Farmer
  • Posted May 16, 2024

Navigating NF1: The Moss Family’s Story of Resilience and Hope

Navigating life with a rare disease like neurofibromatosis type 1 (NF1) can be challenging for families. We had the opportunity to connect with Renie and Philip Moss ahead of NF Awareness Month, and they shared experiences and insights from their NF1 journey. Renie and Philip are a mother and son in Birmingham, Alabama. Renie recounted the initial…


  • By Heather Fecteau, MS, CGC
  • Posted May 1, 2024

Putting Patients First: The Ambry CARE Program®'s Commitment to Patient Experience

With 25 years of innovation experience, Ambry has been a leading pioneer in genetic testing. But Ambry prioritizes more than performing testing. Since the launch of the Ambry CARE Program® in 2019, Ambry has also consistently helped to improve the delivery of genetic services. Why CARE? We know significant gaps exist between medical guidelines…


  • By Meagan Farmer
  • Posted February 21, 2024

A GC’s Perspective on Lab Expertise: Getting Answers After Years of Uncertainty

Kaitlin Stokes is a genetic counselor at Houston Methodist West in Houston, TX. She sees patients with personal or family histories of cancer that may be due to an underlying hereditary cause. We recently connected with Kaitlin about her role, and she shared, “I love what I do because I feel like I’m helping people. I’m giving them control…


  • By Jessica Scott, MGC, CGC
  • Posted January 17, 2024

The Patient Impact of Lab Expertise and Collaboration

“My advice for clinicians and healthcare providers who are ordering genetic testing is [that they] should feel that they are partners with the lab,” explains Chana Ratner, Genetic Counselor at Hackensack University Medical Center. We were grateful for the opportunity to connect with Chana and to discuss her experience as a clinical genetic…